Office blood pressure (OBP) measurement has pro-tions. Additionally, the upcoming ban on the use of mercury in developed countries, already a practice in vided the basis for what is known about the potential risk associated with hypertension and has guided the Scandinavian countries and the Netherlands, has led to the almost inevitable conclusion that the Riva patient management for many years. The mercury sphygmomanometer was the standard method for BP Rocci technique will disappear from clinical practice, and the mercury sphygmomanometer will be replaced measurement since early this century. In the last few years, however, a rapid increase in the use of automatic by accurate, independently-validated automated devices. and semiautomatic devices for measuring BP has been observed in medical and non-medical environments. This was the consequence of awareness of the impor- 
values measured by monitors. This is an important Ambulatory monitoring versus home self issue for nephrologists, because hypertension is preval-measurement ent in renal diseases, and lowering BP is one of the main strategies for reducing the declining rate of There are two methods for measuring ambulatory BP: glomerular filtration and preventing or at least ambulatory BP monitoring (ABPM ) using automatic retarding the progression toward end-stage renal dis-monitors which permit a patient's BP recordings to be ease [1] [2] [3] . Having reliable BP measurements is, there-taken during daily activities and during sleep, and fore, crucial to the management of renal diseases. manually operated or semiautomatic monitors for The present level of knowledge regarding the rela-home BP self-measurement (BPSM ). Both methods tionship between BP and renal disease has been reached make it possible to carrying out a great number of using office BP measurements, data that have the measurements while outside a clinical situation, potential for inaccuracy due to the white-coat effect. avoiding alert reaction during the BP measurement. Recently, however, methods have been introduced They differ, however, in that ABPM permits the assesswhich allow doctors to obtain BP measurements during ment of circadian variability and nocturnal BP, paraa patient's normal daily activities, those outside of a meters not obtained through BPSM. medical environment. One advantage of these ambulatUp to now, the quantity of applicable knowledge ory BP measurements over office BP, derives from the regarding methodological aspects, reference values, more precise estimation of BP values obtained through prognostic and clinical value for ABPM has been much the average of a great number of measurements taken greater than that obtained through BPSM. Still, one under ordinary living conditions outside of the medical of the limitations of ABPM is that repeated monitoring environment [4, 5] . Another advantage is the opportun-may be annoying to patients and, therefore, can only ity to obtain estimates of the BP circadian variability be performed from time to time. A second limitation [6, 7] .
is the relative cost of ABPM. Consequently, BPSM has been advocated as an alternative to ABPM.
The BP values obtained through either ABPM or
The importance of circadian blood pressure
BPSM have demonstrated a better reproducibility variability and night-time dipping [12] [13] [14] , have produced a better correlation with endorgan damage in hypertensive patients and have given The importance of the circadian variability of BP as a better prognosis for cardiovascular morbidity and either a marker or a pathogenic factor for kidney mortality [15] [16] [17] than are those results obtained damage has been stressed in many studies. A blunted through office BP. Thus, ambulatory BP values become decline in the physiological BP nocturnal fall, the non-a better marker of cardiovascular and renal risk than dipper pattern, has been observed frequently in patients its office BP counterparts. with renal failure before or during renal replacement Automatic monitoring and self-measurement protherapy: the lower the glomerular filtration rate, the vide close ambulatory BP values, given lower BP values lower the BP decline during the night [8] . The lowest than those measured in office settings [18] . The higher BP reduction during sleep seems to be associated with the BP the higher the differences between office and the highest decline in glomerular filtration rate in ambulatory BP values. Research has been moving to patients with renal failure [9] . A non-dipper pattern is get enough information about what the BP threshold also common in diabetic nephropathy before the latter for starting antihypertensive treatment is, and has been develops into renal failure [10] . Even in the absence assessing what the BP goal is during treatment [19] . of hypertension, a smaller decline in BP during the During the last few years, a great amount of informanight has been observed in microalbuminuric diabetics, tion for defining reference ambulatory BP values has those patients prone to develop overt nephropathy been collected [20, 21] . Reaching an optimal BP goal, [11] .
however, presents many more difficulties. Nonetheless, the relationship of nocturnal fall in BP with kidney damage is a matter of debate. Some evidence supports the potential role of systemic BP
Normal blood pressure values for ABPM and
transmission as a mechanism of inducing renal damage, BPSM whereas other evidence supports the non-dipping pattern as a consequence of the renal damage itself. The interpretation of these data as being the cause or the Using ABPM, the normotensive state was defined as the average of awake BP lower than 130/80 mmHg, consequence is not mutually exclusive. In some cases, higher BP values during night-time may contribute to and hypertension as the average of awake BP equal or greater than 135/85 mmHg [22] . When BPSM was the progression toward renal insufficiency, while in other cases, the values are but a consequence of the used, the reference values defined hypertension as the average of BP values equal to or greater than altered renal function itself. In the latter, higher BP may also participate in accelerating the loss of renal 135/85 mmHg [23] .
As of now, no information is available regarding function, completing a vicious circle. Thus, the assessment of ambulatory BP may provide valuable informa-what the target ambulatory BP is during antihypertensive treatment. Data from a large group of patients tion regarding the risk of renal damage.
enrolled in the HOT study [24] 
The validation studies published were performed the ambulatory BP goal for protecting kidney function will not differ from the BP goal defined by office BP. mainly in adult populations, but a few provided validation in special populations, such as children [37,38], Obtaining BP values as low as possible, in the absence of symptoms of hypotension or coronary heart disease, pregnant women [37,39-43] and the elderly [37, 44] subjects. The increasing use of ABPM in populations should be the main objective. In patients with proteinuria higher than 1 g/24 h, it should be lowered to with special characteristics on arterial compliance and/or pulse pressure amplitude, requires a large an average systolic BP/diastolic BP <125/75 mmHg [2] .
number of validation studies which will allow us to better compile the BP information now available and Assessing nocturnal BP as a target for protecting against kidney damage seems to be important in renal define protocols for the proper use of ABPM in these populations. diseases treatment. The nocturnal BP goal to achieve needs to be defined from prospective studies.
Among the several hundreds of different monitors available for BPSM, only a small percentage have been validated, of which four were deemed satisfactory according to the criteria of the BHS and/or AAMI
Validation of the novel methodologies
protocols [34] .
The introduction of wrist devices deserves comment. During the last few years, monitors placed on the wrist Ambulatory BP is assessed using automatic or semiautomatic devices, with auscultatory or oscillometric providing accurate BP measurements when intraarterial comparisons were used [45], were marketed methods. The methodology of BP measurement is recognized as being a cause for concern. If we are and rapidly gained an important percentage of the market share in Germany and in other European looking for the most accurate BP values, the characteristics and capacities of the monitors becomes a key countries. Despite the resulting good grades the validation studies offered, a comparison of the values point. The validation of new devices have been performed testing agreement among monitors and mer-obtained on the wrist with those obtained on the arm resulted in a great variability. Other concerns are that cury sphygmomanometer. A small number of studies used as reference the Hawksley random-zero sphygmo-differences between arm and wrist BP are variable as a function of arterial stiffness, and that the wrist device manometer which is susceptible to unintentional misuse [25] , but in this case the obtained grades for the tested placement seems to offer more difficulties than does that for arm cuffs. monitor were lower than those obtained against mercury sphygmomanometer [26 ] .
Reliability in the reporting of BPSM values needs to be mentioned as a potential drawback. A recent There are four validation protocols available [27-30]. The two most widely accepted are those study [46 ] , compared automatic stored BP measurements with the respective logbook entries in a group released by the Association for the Advancement of Medical Instrumentation (AAMI ) [27] and by the of thirty well-trained hypertensives. The authors found a substantial observer error in the reporting of BPSM British Hypertension Society (BHS ) [28] . The other two are locally used in Germany [29] and in Australia values. The percentage of reporting errors was close to that observed with reported home blood glucose [30] . These protocols, which differ in detail, but have a common objective the standardization of validation levels in type 1 diabetics [47] . The impact of reporting errors needs to be considered when BPSM is to establish minimum standards of accuracy and performance and to facilitate comparison of one device contemplated.
Efforts are necessary for developing accurate autowith another.
The AAMI protocol qualifies a monitor as it passes mated monitors suitable for self-measurement, ABPM or office and hospital use. Developing new devices or fails the established criteria (mean difference must be <5 mmHg and standard deviation <8 mmHg) need to redefine the validation protocols [48] Conclusion had been validated either using the AAMI or the BHS protocols. Nine of these had failed to adhere to the protocols thereby rendering the results questionable, In summary, the management of patients with renal diseases may be improved by assessing ambulatory BP. and further nine devices fulfilled the requirements of both protocols [33] . In 1998, twenty-seven validation Several monitors are now available which meet the 20. Mancia G, Sega R, Bravi C et al. 
